PA Lookup
If you have questions about prior authorizations, please call:
Member and Recipient Service Line: 1-877-685-2415
Provider Support Service Line: 1-855-250-1539
Stapedectomy or stapedotomy with reestablishment of ossicular continuity, with or without use of foreign material;
How to Submit
N/A - No authorization is required
Stapedectomy or stapedotomy with reestablishment of ossicular continuity, with or without use of foreign material; with footplate drill out
How to Submit
N/A - No authorization is required
Revision of stapedectomy or stapedotomy
How to Submit
N/A - No authorization is required
Repair oval window fistula
How to Submit
N/A - No authorization is required
Repair round window fistula
How to Submit
N/A - No authorization is required
Mastoid obliteration (separate procedure)
How to Submit
N/A - No authorization is required
Tympanic neurectomy
How to Submit
N/A - No authorization is required
Closure postauricular fistula, mastoid (separate procedure)
How to Submit
N/A - No authorization is required
Implantation or replacement of electromagnetic bone conduction hearing device in temporal bone
How to Submit
N/A - No authorization is required
Removal or repair of electromagnetic bone conduction hearing device in temporal bone
How to Submit
N/A - No authorization is required
Implantable Bone Conduction Hearing Aids (BAHA)
A bone-anchored hearing aid (BAHA) is a surgically implanted osseointegrated prosthetic device that provides bone conduction hearing for recipients with moderate to severe, bilateral conductive or mixed hearing loss who cannot wear a conventional air-conduction hearing aid or cannot reasonably or satisfactorily undergo ossicular replacement surgery. A BAHA device includes the implantation of a titanium abutment to which an external speech processor is attached.
Authorization Guidelines
The provider(s) shall submit the following: a. the prior approval request; and b. all health records and any other records that support the beneficiary has met the specific criteria in this policy
Limits
Implantable bone conduction hearing aid devices must be FDA approved for the population being considered.
Exclusions
The BAHA is not covered when:
- a. the beneficiary has a disease state that may jeopardize osseointegration;
- b. the beneficiary can gain sufficient benefit from conventional amplification; or
- c. the beneficiary’s audiometric criteria are outside the range of specifications
Age Group Details
Coverage is limited to beneficiaries 5 through 20 years of age for the implantable device service. Medically necessary maintenance and upgrades of existing internal components for next-generation devices are covered only for beneficiaries ages 5 years and older.
Place of Service
Hospital inpatient, hospital outpatient, ambulatory surgical center. No numeric place of service codes are listed in the policy.
Additional Service Specifics
Implantable bone conduction hearing aid devices shall be FDA approved for the population being considered.
How to Submit
Please submit your request to Trillium Health Resources
Resources
Implantable Bone Conduction Hearing Aids (BAHA)
A bone-anchored hearing aid (BAHA) is a surgically implanted osseointegrated prosthetic device that provides bone conduction hearing for recipients with moderate to severe, bilateral conductive or mixed hearing loss who cannot wear a conventional air-conduction hearing aid or cannot reasonably or satisfactorily undergo ossicular replacement surgery. A BAHA device includes the implantation of a titanium abutment to which an external speech processor is attached.
Authorization Guidelines
The provider(s) shall submit the following: a. the prior approval request; and b. all health records and any other records that support the beneficiary has met the specific criteria in this policy
Limits
Implantable bone conduction hearing aid devices must be FDA approved for the population being considered.
Exclusions
The BAHA is not covered when:
- a. the beneficiary has a disease state that may jeopardize osseointegration;
- b. the beneficiary can gain sufficient benefit from conventional amplification; or
- c. the beneficiary’s audiometric criteria are outside the range of specifications
Age Group Details
Coverage is limited to beneficiaries 5 through 20 years of age for the implantable device service. Medically necessary maintenance and upgrades of existing internal components for next-generation devices are covered only for beneficiaries ages 5 years and older.
Place of Service
Hospital inpatient, hospital outpatient, ambulatory surgical center. No numeric place of service codes are listed in the policy.
Additional Service Specifics
Implantable bone conduction hearing aid devices shall be FDA approved for the population being considered.
How to Submit
Please submit your request to Trillium Health Resources
Resources
Implantation, osseointegrated implant, skull; with magnetic transcutaneous attachment to external speech processor
Authorization Guidelines
Please submit any records and any other information that you believe support the member has met the applicable medical necessity criteria to Trillium.
How to Submit
Please submit your request to Trillium Health Resources
Implantable Bone Conduction Hearing Aids (BAHA)
A bone-anchored hearing aid (BAHA) is a surgically implanted osseointegrated prosthetic device that provides bone conduction hearing for recipients with moderate to severe, bilateral conductive or mixed hearing loss who cannot wear a conventional air-conduction hearing aid or cannot reasonably or satisfactorily undergo ossicular replacement surgery. A BAHA device includes the implantation of a titanium abutment to which an external speech processor is attached.
Limits
Implantable bone conduction hearing aid devices must be FDA approved for the population being considered.
Exclusions
The BAHA is not covered when:
- a. the beneficiary has a disease state that may jeopardize osseointegration;
- b. the beneficiary can gain sufficient benefit from conventional amplification; or
- c. the beneficiary’s audiometric criteria are outside the range of specifications
Age Group Details
Coverage is limited to beneficiaries 5 through 20 years of age for the implantable device service. Medically necessary maintenance and upgrades of existing internal components for next-generation devices are covered only for beneficiaries ages 5 years and older.
Place of Service
Hospital inpatient, hospital outpatient, ambulatory surgical center. No numeric place of service codes are listed in the policy.
Additional Service Specifics
Implantable bone conduction hearing aid devices shall be FDA approved for the population being considered.
How to Submit
N/A - No authorization is required
Resources
Implantable Bone Conduction Hearing Aids (BAHA)
A bone-anchored hearing aid (BAHA) is a surgically implanted osseointegrated prosthetic device that provides bone conduction hearing for recipients with moderate to severe, bilateral conductive or mixed hearing loss who cannot wear a conventional air-conduction hearing aid or cannot reasonably or satisfactorily undergo ossicular replacement surgery. A BAHA device includes the implantation of a titanium abutment to which an external speech processor is attached.
Authorization Guidelines
The provider(s) shall submit the following: a. the prior approval request; and b. all health records and any other records that support the beneficiary has met the specific criteria in this policy
Limits
Implantable bone conduction hearing aid devices must be FDA approved for the population being considered.
Exclusions
The BAHA is not covered when:
- a. the beneficiary has a disease state that may jeopardize osseointegration;
- b. the beneficiary can gain sufficient benefit from conventional amplification; or
- c. the beneficiary’s audiometric criteria are outside the range of specifications
Age Group Details
Coverage is limited to beneficiaries 5 through 20 years of age for the implantable device service. Medically necessary maintenance and upgrades of existing internal components for next-generation devices are covered only for beneficiaries ages 5 years and older.
Place of Service
Hospital inpatient, hospital outpatient, ambulatory surgical center. No numeric place of service codes are listed in the policy.
Additional Service Specifics
Implantable bone conduction hearing aid devices shall be FDA approved for the population being considered.
How to Submit
Please submit your request to Trillium Health Resources
Resources
Revision or replacement (including removal of existing device), osseointegrated implant, skull; with magnetic transcutaneous attachment to external speech processor
How to Submit
N/A - No authorization is required
Decompression facial nerve, intratemporal; lateral to geniculate ganglion
How to Submit
N/A - No authorization is required
Decompression facial nerve, intratemporal; including medial to geniculate ganglion
How to Submit
N/A - No authorization is required
Removal, osseointegrated implant, skull; with percutaneous attachment to external speech processor
How to Submit
N/A - No authorization is required
Removal, osseointegrated implant, skull; wwith magnetic transcutaneous attachment to external speech processor
How to Submit
N/A - No authorization is required
If you find any wrong or out of date information on our pages, we want to know. Please email info@TrilliumNC.org with any corrections.